Literature DB >> 23073804

Over-expression of VEGF in marrow stromal cells promotes angiogenesis in rats with cerebral infarction via the synergistic effects of VEGF and Ang-2.

Tianbao Lai1,2, Man Li1, Lifang Zheng3, Yanling Song4, Xiaoli Xu5, Yuanjin Guo1, Yuan Zhang1, Zongsheng Zhang1, Yuanwu Mei6.   

Abstract

bThis study explored whether the transplantation of modified marrow stromal cells (MSCs) has angiogenic effects in a left middle cerebral artery occlusion infarction/reperfusion (MCAO I/R) rat model and preliminarily examined the mechanism of angiogenesis following cerebral infarction. MSCs were isolated by using a direct adherent method and cultured. Vascular endothelial growth factor (VEGF) was transfected into MSCs by employing the liposome transfection. The transfection efficiency was measured by the optical density method. The protein expression of VEGF gene before and after transfection was measured by Western blotting. SD rat model of transient occlusion of the left middle cerebral artery was established by using an approach of intra-luminal occlusion. Tetrazolium (TTC) and HE staining were performed to observe the cerebral infarction. ELISAs were used to measure the levels of VEGF in the rat cerebral tissues. The expression patterns of angiopoietin-2 (Ang-2) and CD34 in cells surrounding the area of infarction were immunohistochemistrically observed. Ang-2 protein expression in the tissue surrounding the area of infarction was measured by Western blotting. VEGF expression in the MSCs increased after transfection at a rate of approximately 28%±3.4%. ELISA showed that the expression of VEGF in the cerebral tissue was significantly increased after induction of infarction, peaking on the 4th day and decreasing to the levels of the sham surgery group (normal) within 7 to 10 days. The VEGF level was significantly higher at each time point in the VEGF-MSC and MSC groups compared to the model group. Moreover, the VEGF level was higher in the VEGF-MSC group than in the MSC group and stayed relatively high until the 10th day. The immunohistochemical results showed that 10 days after the infarction, the number of Ang-2 and CD34-expressing cells in the area surrounding the infarction was significantly higher in the VEGF-MSC group and the MSC group compared to the model group. Moreover, the VEGF level was higher in the VEGF-MSC group than the MSC group. A similar trend in Ang-2 protein expression was revealed by Western blotting. In the MCAO rat model transfected with modified MSCs over-expressing VEGF, compared to the MSC transplantation group, the concentration of VEGF was significantly increased in the brain tissue after cerebral infarction. In addition, the level of Ang-2 was up-regulated, with angiogenesis promoted, the blood supply to the areas surrounding the cerebral infarction increased, and neurological function improved. We are led to speculate that the synergistic effects of VEGF and Ang-2 may be responsible for the angiogenesis following cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073804     DOI: 10.1007/s11596-012-1025-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  26 in total

1.  Immortalized multipotential mesenchymal cells and the hematopoietic microenvironment.

Authors:  S P Dormady; O Bashayan; R Dougherty; X M Zhang; R S Basch
Journal:  J Hematother Stem Cell Res       Date:  2001-02

2.  Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.

Authors:  Yongfeng Fan; Fanxia Shen; Tim Frenzel; Wei Zhu; Jianqin Ye; Jianrong Liu; Yongmei Chen; Hua Su; William L Young; Guo-Yuan Yang
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

3.  [Differentiation of mesenchymal stem cells into cardiomyocytes induced by cardiomyocytes].

Authors:  Ting-Zhong Wang; Ai-Qun Ma; Zheng-Yun Xu; Wen-Hui Jiang; Yuan Du
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2005-06

4.  VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.

Authors:  Samuel Valable; Joan Montaner; Anita Bellail; Vincent Berezowski; Julien Brillault; Romeo Cecchelli; Didier Divoux; Eric T Mackenzie; Myriam Bernaudin; Simon Roussel; Edwige Petit
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

5.  Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.

Authors:  H Liu; O Honmou; K Harada; K Nakamura; K Houkin; H Hamada; J D Kocsis
Journal:  Brain       Date:  2006-08-10       Impact factor: 13.501

6.  Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model.

Authors:  Agnieszka A Ardelt; Louise D McCullough; Kenneth S Korach; Michael M Wang; Diane H Munzenmaier; Patricia D Hurn
Journal:  Stroke       Date:  2005-01-06       Impact factor: 7.914

Review 7.  Development of non-viral vector for cancer gene therapy.

Authors:  Yoshiyuki Hattori
Journal:  Yakugaku Zasshi       Date:  2010-07       Impact factor: 0.302

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

9.  Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.

Authors:  Toshiyuki Onda; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada; Jeffery D Kocsis
Journal:  J Cereb Blood Flow Metab       Date:  2007-07-18       Impact factor: 6.200

10.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  9 in total

1.  Neuroprotective effect of lentivirus mediated VEGF on rat model with cerebral ischemic injury.

Authors:  Junhe Zhang; Xiaojuan Li; Shujie Chai; Xiaoyin Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Is the regulation of SIRT1 by miRNA-34a the key to mesenchymal stem cell survival?

Authors:  Michael A Bellio; Wayne Balkan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Ann Transl Med       Date:  2016-06

3.  Catgut implantation at acupoints increases the expression of glutamate aspartate transporter and glial glutamate transporter-1 in the brain of rats with spasticity after stroke.

Authors:  Rui-Qing Li; Ming-Yue Wan; Jing Shi; Hui-Ling Wang; Fei-Lai Liu; Cheng-Mei Liu; Jin Huang; Ren-Chao Liu; Le Ma; Xiao-Dong Feng
Journal:  Neural Regen Res       Date:  2018-06       Impact factor: 5.135

4.  Combination therapy of human bone marrow-derived mesenchymal stem cells and minocycline improves neuronal function in a rat middle cerebral artery occlusion model.

Authors:  Dong Young Cho; Sin-Soo Jeun
Journal:  Stem Cell Res Ther       Date:  2018-11-09       Impact factor: 6.832

5.  DHA Attenuates Hypoxia/Reoxygenation Injury by Activating SSeCKS in Human Cerebrovascular Pericytes.

Authors:  Yanli Yu; Haibin Fang; Zhen Qiu; Zhongyuan Xia; Bin Zhou
Journal:  Neurochem Res       Date:  2019-11-27       Impact factor: 3.996

6.  A Comparative Animal Study of Tendon Grafts Healing After Remnant-Preserving Versus Conventional Anterior Cruciate Ligament Reconstruction.

Authors:  Lei Zhang; Kan Jiang; Hao Chai; Mei Zhou; Jingping Bai
Journal:  Med Sci Monit       Date:  2016-09-26

7.  Effects of thymosin β4 on neuronal apoptosis in a rat model of cerebral ischemia‑reperfusion injury.

Authors:  Zhongsheng Zhang; Shuangfeng Liu; Sichun Huang
Journal:  Mol Med Rep       Date:  2019-09-13       Impact factor: 2.952

8.  Therapeutic efficacy of neuregulin 1-expressing human adipose-derived mesenchymal stem cells for ischemic stroke.

Authors:  Sun Ryu; Jae-Min Lee; Cheong A Bae; Chae-Eun Moon; Kyung-Ok Cho
Journal:  PLoS One       Date:  2019-09-27       Impact factor: 3.240

Review 9.  Theranostic cells: emerging clinical applications of synthetic biology.

Authors:  Monica P McNerney; Kailyn E Doiron; Tai L Ng; Timothy Z Chang; Pamela A Silver
Journal:  Nat Rev Genet       Date:  2021-07-07       Impact factor: 53.242

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.